Diagnostic needs for Antimicrobial Resistance (360G-Wellcome-210854_Z_18_Z)

Despite various calls for action and some initial work to map diagnostics for AMR, no authoritative list exist for commercially available (or under development) in vitro diagnostics for antimicrobial resistance (AMR in vitro diagnostics). Similarly, Target Product Profiles to guide the development of these diagnostics are also lacking. Multiple stakeholders including the diagnostic industry, academia and NGOs have stressed the need to address this gap. In response to this scenario, WHO will coordinate the mapping of diagnostic tools (both existing and in development) to address antimicrobial resistance; identify gaps and establish a WHO R & D priority list for AMR in vitro diagnostics. Target Product Profiles for high priority AMR in vitro diagnostics will also be developed, published and disseminated to relevant stakeholders.